FR2593826B1 - Anticorps monoclonaux a reactivite et a protectivite croisees vis-a-vis des serotypes de p. aeruginosa - Google Patents

Anticorps monoclonaux a reactivite et a protectivite croisees vis-a-vis des serotypes de p. aeruginosa

Info

Publication number
FR2593826B1
FR2593826B1 FR868617264A FR8617264A FR2593826B1 FR 2593826 B1 FR2593826 B1 FR 2593826B1 FR 868617264 A FR868617264 A FR 868617264A FR 8617264 A FR8617264 A FR 8617264A FR 2593826 B1 FR2593826 B1 FR 2593826B1
Authority
FR
France
Prior art keywords
protectivity
reactivity
cross
monoclonal antibodies
aeruginosa serotypes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR868617264A
Other languages
English (en)
French (fr)
Other versions
FR2593826A1 (fr
Inventor
Anthony W Siadak
Mae J Rosok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of FR2593826A1 publication Critical patent/FR2593826A1/fr
Application granted granted Critical
Publication of FR2593826B1 publication Critical patent/FR2593826B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR868617264A 1985-12-10 1986-12-10 Anticorps monoclonaux a reactivite et a protectivite croisees vis-a-vis des serotypes de p. aeruginosa Expired - Fee Related FR2593826B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (2)

Publication Number Publication Date
FR2593826A1 FR2593826A1 (fr) 1987-08-07
FR2593826B1 true FR2593826B1 (fr) 1990-11-16

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868617264A Expired - Fee Related FR2593826B1 (fr) 1985-12-10 1986-12-10 Anticorps monoclonaux a reactivite et a protectivite croisees vis-a-vis des serotypes de p. aeruginosa

Country Status (21)

Country Link
US (4) US5378812A (enrdf_load_stackoverflow)
JP (1) JPH07116237B2 (enrdf_load_stackoverflow)
KR (1) KR910008361B1 (enrdf_load_stackoverflow)
CN (1) CN86108380A (enrdf_load_stackoverflow)
AT (1) AT400441B (enrdf_load_stackoverflow)
BE (1) BE905890A (enrdf_load_stackoverflow)
CH (1) CH677362A5 (enrdf_load_stackoverflow)
DE (1) DE3642095C2 (enrdf_load_stackoverflow)
DK (1) DK594586A (enrdf_load_stackoverflow)
FI (1) FI86377C (enrdf_load_stackoverflow)
FR (1) FR2593826B1 (enrdf_load_stackoverflow)
GB (1) GB2185266B (enrdf_load_stackoverflow)
HU (1) HUT41836A (enrdf_load_stackoverflow)
IE (1) IE59741B1 (enrdf_load_stackoverflow)
IT (1) IT1199735B (enrdf_load_stackoverflow)
LU (1) LU86711A1 (enrdf_load_stackoverflow)
NL (1) NL8603132A (enrdf_load_stackoverflow)
NO (1) NO178718C (enrdf_load_stackoverflow)
NZ (1) NZ218499A (enrdf_load_stackoverflow)
PT (1) PT83894B (enrdf_load_stackoverflow)
SE (1) SE468831B (enrdf_load_stackoverflow)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
EP0327648B1 (en) * 1986-12-15 1993-06-09 MITSUI TOATSU CHEMICALS, Inc. Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
FI905644A7 (fi) * 1989-03-20 1990-11-14 Mitsui Toatsu Chemicals Incorporated Pseudomonas aeruginosan kanssa reaktiokykyiset ihmisen monoklonaaliset vasta-aineet, niitä tuottamaan kykenevät solut, niiden valmistusmenete lmät ja niitä sisältävätfarmaseuttiset valmisteet
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
AU5675790A (en) * 1989-05-09 1990-11-29 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
US9017963B2 (en) * 2002-01-31 2015-04-28 Woundchek Laboratories (Us), Inc. Method for detecting microorganisms
WO2003102142A2 (en) * 2002-05-29 2003-12-11 Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. Arrays identifying genomic and proteomic biomarkers for cystic fibrosis
ES2381998T3 (es) 2002-11-26 2012-06-04 The University Of Chicago Prevención y tratamiento de trastornos eipiteliales mediados por microbios
PL215172B1 (pl) * 2003-01-31 2013-10-31 Ethicon Inc Sposób wykrywania Escherichia coli, biosensor do wykrywania Escherichia coli i zestaw do wykrywania Escherichia coli
ATE382862T1 (de) 2003-11-03 2008-01-15 Ethicon Inc Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
EP2012669B1 (en) * 2006-05-01 2013-03-13 Bioness Neuromodulation Ltd Improved functional electrical stimulation systems
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
US20130004499A1 (en) * 2010-02-18 2013-01-03 Symphogen A/S Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
EP0168422A1 (en) * 1983-12-12 1986-01-22 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
EP0233289B1 (en) * 1984-12-26 1993-03-10 Teijin Limited Hybridomas producing anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
DE3689713T2 (de) * 1985-08-01 1994-07-07 Miles Inc Schützende Antikörper gegen serotypische Determinanten von flagellären Antigenen.
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
SE468831B (sv) 1993-03-29
NZ218499A (en) 1990-04-26
DK594586D0 (da) 1986-12-10
FR2593826A1 (fr) 1987-08-07
DK594586A (da) 1987-06-11
JPH07116237B2 (ja) 1995-12-13
KR870005648A (ko) 1987-07-06
NO864971D0 (no) 1986-12-10
FI865027A0 (fi) 1986-12-10
DE3642095C2 (de) 1998-10-01
US5662905A (en) 1997-09-02
DE3642095A1 (de) 1987-07-02
ATA328286A (de) 1995-05-15
PT83894A (en) 1987-01-01
NO178718C (no) 1996-05-22
US5628996A (en) 1997-05-13
FI86377C (fi) 1992-08-25
IT1199735B (it) 1988-12-30
NO178718B (no) 1996-02-12
AT400441B (de) 1995-12-27
FI86377B (fi) 1992-05-15
IE863230L (en) 1987-06-10
GB2185266B (en) 1990-09-05
CN86108380A (zh) 1987-10-28
KR910008361B1 (ko) 1991-10-12
BE905890A (fr) 1987-06-10
CH677362A5 (enrdf_load_stackoverflow) 1991-05-15
LU86711A1 (fr) 1988-07-14
GB2185266A (en) 1987-07-15
GB8629540D0 (en) 1987-01-21
JPS62187417A (ja) 1987-08-15
US5627067A (en) 1997-05-06
FI865027A7 (fi) 1987-06-11
SE8605295D0 (sv) 1986-12-10
IT8622630A0 (it) 1986-12-10
PT83894B (pt) 1989-07-31
SE8605295L (sv) 1987-06-11
NL8603132A (nl) 1987-07-01
US5378812A (en) 1995-01-03
IE59741B1 (en) 1994-03-23
HUT41836A (en) 1987-05-28
NO864971L (no) 1987-06-11

Similar Documents

Publication Publication Date Title
FR2593826B1 (fr) Anticorps monoclonaux a reactivite et a protectivite croisees vis-a-vis des serotypes de p. aeruginosa
DE3584559D1 (de) Therapeutische antikoerpermittelkonjugate.
FI862370A7 (fi) Monoklonaalisia vasta-aineita syklosporiineille
FI885361A7 (fi) Lääkeaine-monoklonaaliset vasta-aine-konjugaatit
FI925631L (fi) Monoklonala antikroppar
ES263116Y (es) &#34;un sistema de fijacion de carriles&#34;.
DE3676435D1 (de) Schwungradvorrichtung.
OA06439A (fr) Perfectionnements aux biberons d&#39;allaitement.
IT1151917B (it) Dispositivo per produrre una successione di segnali dipendente dal numero di giri
GB8528191D0 (en) Common antigen to pseudomonas aeruginosa
DK188185D0 (da) Monoklonalt antistof
KR880701561A (ko) 피브린에 대한 단클론의 항체
DK37785D0 (da) Monoclonalt antistof
IT8025911A0 (it) Albero a gomiti con gomiti simmetrici.
DK144485D0 (da) Monoklonale antistoffer
DK717888A (da) Monoklonale antistoffer
IT1242055B (it) Dispositivo per giuntare stoppino.
FI870482A7 (fi) Suojaavat ihmisen monoklonaaliset vasta-aineet Pseudomonas aeruginosan eksotoksiini A:lle.
FR2500754B1 (fr) Anticorps monoclonaux
BR7908558A (pt) Bola
OA08559A (fr) Anticorps monoclonaux à réactivité et à protectivité croisées vis-à-vis des sérotypes de P. Aeruginosa.
FR2503818B1 (fr) Volant d&#39;inertie
DK147306C (da) Forskalling med et i det vaesentlige vandret forskallingsdaek
DE3576847D1 (de) Verbrennungsvorrichtung.
IT1165415B (it) Bobina clemente victoria

Legal Events

Date Code Title Description
ST Notification of lapse